The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Morgan Stanley is the larger company, worth $310.0B, about 11.2 times Nomura Holdings Inc ADR.
  • Morgan Stanley grew revenue faster over the last year (+27.1% vs +12.7%).
  • On earnings, Nomura Holdings Inc ADR is the cheaper stock (12.6x vs 17.8x).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureMSNMR
Market cap$310.0B$27.7B
Share price$190.02$9.59
Revenue (last fiscal year)$70.6B$1.20T
Free cash flow (last fiscal year)—-$1.20T
Revenue growth, last year+27.1%+12.7%
Revenue growth per year, last 5 fiscal years+4.3%+11.1%
Operating margin——
Net margin25.8%30.1%
Return on equity17.3%11.0%
P/E (trailing)17.8x12.6x
Price / free cash flow6.73x—
EV / EBITDA7.76x—
FCF growth the price implies——
Dividend yield2.1%4.3%
Debt / equity13.4x15.6x
Fundamental gradeBC
Superinvestors holding it122
Insider purchases, last 12 months100

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Morgan Stanley

YearRevenueFree cash flowOp. margin
2021$59.8B——
2022$53.7B——
2023$54.1B——
2024$61.8B——
2025$70.6B——

Nomura Holdings Inc ADR

YearRevenueFree cash flowOp. margin
2022$790.8B-$974.2B—
2023$707.9B-$866.0B—
2024$896.5B-$13.1B—
2025$1.07T-$868.6B—
2026$1.20T-$1.20T—

Where the revenue comes from

Morgan Stanley · by segments, 2025

IS$33.1B46%
WM$31.8B44%
IM$6.5B9%

Nomura Holdings Inc ADR · by regions, 2026

Japan$1.09T50%
Americas$670.0B31%
Europe$261.5B12%
Asia and Oceania$148.4B7%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open MS in Investingly

Questions

Which is bigger, Morgan Stanley or Nomura Holdings Inc ADR?

Morgan Stanley (MS), at $310.0B against $27.7B.

Is MS or NMR cheaper?

By trailing P/E, Nomura Holdings Inc ADR (12.6x) is cheaper than Morgan Stanley (17.8x). A lower multiple can also mean the market expects less growth.

Which grows faster, MS or NMR?

Morgan Stanley: revenue grew +27.1% over the last year, against +12.7%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.